We also identified the correlation between the OTUB1/β-catenin/necroptosis axis and chemotherapy response in BLCA, demonstrating that elevated OTUB1 promotes cisplatin resistance, which is reversed by XAV-939 application. Here, OTUB1 is linked to bladder transitional cell carcinoma.